Sarilumab monotherapy compared with adalimumab monotherapy for the treatment of moderately to severely active rheumatoid arthritis: an analysis of incremental cost per effectively... oleh Fournier M, Chen C, Kuznik A, Proudfoot C, Mallya UG, Michaud K